Lung Cancer

Carcinoma of Upper Lobe of Right Lung

Male, 62 years

Patient Internal ID: 102389711

ICD-10 code

C34.1 Malignant Neoplasm of Upper Lobe, Bronchus or Lung

Diagnosis (Incl. Metastases/Stage) and Year

December 2010
Carcinoma of Upper Lobe of Right Lung pT1a N0M0R0 G2 I st.
May 2020 disease progression.
Pleomorphic Carcinoma of the Lung with Partial  Neuroendocrine Differentiation with Metastasis in both Lungs pT1aNxM1.

Previous Treatment

Surgery (Segmentectomy), Target Therapy (Erlotinib), Radiation Therapy, Surgery (Segmentectomy – 2nd), Chemotherapy (Carboplatin, Paclitaxel), Chemotherapy (Gemcitabine).

Prognosis and Survival Expectation

The prognosis remains poor, with a median survival of ~1 year from diagnosis.

Treatment Provided

Autologous DCV (10 doses) and CIK (4 doses) over a period of 14 months. Additionally, the patient received Umbilical Cord Blood Derived NK cells (8 doses).

Patient Survival/Condition and Year
Date of Review: 15/10/2023

After the disease progression, the patient survived for 3 years. It can be concluded that Immunotherapy, alongside Surgery, Chemotherapies and Radiation Therapy, has extended the patient’s survival by around 2 years compared with median survival.